Question 1

What specific information will this study provide about COVID-19 and MS?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients clinical trial (NCT04498286). Contact the study team or your healthcare provider for specific answers.

Question 2

How might my current MS treatment affect my risk for COVID-19?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients clinical trial (NCT04498286). Contact the study team or your healthcare provider for specific answers.

Question 3

What will happen if I test positive for SARS-CoV-2 antibodies?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients clinical trial (NCT04498286). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to participate in follow-up assessments if I join this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients clinical trial (NCT04498286). Contact the study team or your healthcare provider for specific answers.

Question 5

What are the potential benefits of knowing my antibody status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients clinical trial (NCT04498286). Contact the study team or your healthcare provider for specific answers.

What this study is about